KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-cash Items (2016 - 2022)

Pacific Biosciences Of California has reported Non-cash Items over the past 10 years, most recently at $24.7 million for Q4 2022.

  • Quarterly results put Non-cash Items at $24.7 million for Q4 2022, down 79.9% from a year ago — trailing twelve months through Dec 2022 was $24.7 million (down 79.9% YoY), and the annual figure for FY2022 was $24.7 million, down 79.9%.
  • Non-cash Items for Q4 2022 was $24.7 million at Pacific Biosciences Of California, down from $122.9 million in the prior quarter.
  • Over the last five years, Non-cash Items for PACB hit a ceiling of $298.8 million in Q4 2020 and a floor of $20.0 million in Q4 2019.
  • Median Non-cash Items over the past 5 years was $58.0 million (2018), compared with a mean of $104.9 million.
  • Biggest five-year swings in Non-cash Items: soared 3311.76% in 2018 and later crashed 79.9% in 2022.
  • Pacific Biosciences Of California's Non-cash Items stood at $58.0 million in 2018, then tumbled by 65.52% to $20.0 million in 2019, then soared by 1394.0% to $298.8 million in 2020, then crashed by 58.87% to $122.9 million in 2021, then crashed by 79.9% to $24.7 million in 2022.
  • The last three reported values for Non-cash Items were $24.7 million (Q4 2022), $122.9 million (Q4 2021), and $298.8 million (Q4 2020) per Business Quant data.